CD274 and head and neck squamous cell carcinoma: Therefore, it is still unclear which PD‐L1 expression measurement method is more sensitive and whether the currently used CPS cut‐off value best predicts the clinical outcome in R/M‐HNSCC patients treated with APA monotherapy.